McKesson Q1 Earnings Surpass Wall Street Estimate; Raises FY22 EPS Outlook

View more earnings on MCKSee more from BenzingaClick here for options trades from BenzingaAmgen Stops Phase 1 For One BiTE Molecule While Resuming Dosing For Another, Plans Second Drug Substance PlantWHO Asks To Hold Off COVID-19 Vaccine Booster Shots Citing Inequality: Report© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

McKesson Q1 Earnings Surpass Wall Street Estimate; Raises FY22 EPS Outlook

View more earnings on MCKSee more from BenzingaClick here for options trades from BenzingaAmgen Stops Phase 1 For One BiTE Molecule While Resuming Dosing For Another, Plans Second Drug Substance PlantWHO Asks To Hold Off COVID-19 Vaccine Booster Shots Citing Inequality: Report© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.